SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMhp Reg S Regulatory News (MHPC)

Share Price Information for Mhp Reg S (MHPC)

Share Price is delayed by 15 minutes
Get Live Data
8.80    0.50 (6.02%)
Bid:
8.80
Ask:
9.00
Spread: 0.20 (2.273%)
Market Cap: $941.94m
MHPC Live PriceLast checked at - London Stock Exchange

Intraday Mhp Reg S Share Chart

  • This share is an international stock.

MHP 2026 NOTES CONDITIONAL REDEMPTION ANNOUNCEMENT

15 Jan 2026 13:28

RNS Number : 1085P
MHP SE
15 January 2026
 

15 January 2026

 

MHP 2026 NOTES CONDITIONAL REDEMPTION ANNOUNCEMENT

MHP SE ("MHP"), the parent company of a leading international food and agricultural group headquartered in Ukraine and one of the largest poultry producers in Southeast Europe, has announced that its wholly owned subsidiary MHP Lux S.A. will conditionally redeem on 18 February 2026 all of MHP Lux S.A.'s 6.95% Notes due 2026 that remain outstanding on the same date following the settlement of the tender offer announced by MHP today, in accordance with the terms of the indenture dated as of 3 April 2018 (as amended and restated from time to time) governing such Notes. This redemption will be conditional on (i) the consummation of the issuance by MHP Lux S.A. of the dollar-denominated senior fixed rate notes due 2029, which MHP announced its intention to issue today, and (ii) the receipt by MHP Lux S.A. through said issuance of gross proceeds of at least U.S.$450 million which, together with a cash balance of U.S.$100 million, is sufficient to permit the company to repurchase and/or redeem all of the US.$550 million principal amount of the 6.95% Notes due 2026.

Disclaimer

This announcement does not contain or constitute an offer of, or the solicitation of an offer to buy securities to any person in the United States or in any jurisdiction to whom or in which such offer or solicitation is unlawful, and persons into whose possession this announcement comes should inform themselves about, and observe, any such restrictions. The securities referred to herein may not be offered or sold in the United States absent registration under the US Securities Act of 1933, as amended (the "Securities Act"), or another exemption from, or in a transaction not subject to, the registration requirements of the Securities Act. Subject to certain exceptions, the securities referred to herein may not be offered or sold in Australia, Canada or Japan or to, or for the account or benefit of, any national, resident or citizen of Australia, Canada or Japan. The offer and sale of the securities referred to herein has not been and will not be registered under the Securities Act or under the applicable securities laws of Australia, Canada or Japan. There will be no public offer of the securities in the United States.

This announcement is only being distributed to and is only directed at (i) persons who are outside the United Kingdom or (ii) to investment professionals falling within Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (the "Order") or (iii) high net worth entities, and other persons to whom it may lawfully be communicated, falling within Article 49(2)(a) to (d) of the Order (all such persons together being referred to as relevant persons). The securities are only available to, and any invitation, offer or agreement to subscribe, purchase or otherwise acquire such securities will be engaged in only with, relevant persons. Any person who is not a relevant person should not act or rely on this announcement or any of its contents.

In member states of the European Economic Area ("EEA"), this announcement is directed only at persons who are "qualified investors" within the meaning of Article 2(e) of Regulation (EU) 2017/1129, as amended.

Singapore Securities and Futures Act Product Classification - Solely for the purposes of its obligations pursuant to sections 309B(1)(a) and 309B(1)(c) of the Securities and Futures Act (Chapter 289 of Singapore) (the "SFA"), MHP has determined, and hereby notifies all relevant persons (as defined in Section 309A of the SFA) that the Notes are "prescribed capital markets products" (as defined in the Securities and Futures (Capital Markets Products) Regulations 2018).

This announcement is not an advertisement of securities in Ukraine, and is not an offer or invitation to, or solicitation of, any such circulation, distribution, placement, sale, purchase or other transfer of the securities in the territory of Ukraine. It is not intended to be and must not be publicly distributed in or into Ukraine.

Please address any questions or concerns to:

Anastasiya Sobotyuk (Kyiv)

+38 050 339 29 99

IR Director, ESG Compliance and Reporting

a.sobotyuk@mhp.com.ua

Christakis Taoushanis (Cyprus)

+357 99 35 22 22

Senior Independent Director

t.taoushanis@mhp.com.cy

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCBXGDBSDBDGLU
Date   Source Headline
1st Jun 20267:00 amRNSMHP SE to acquire up to 100% of Th. Nitsiakos AVEE
8th May 20267:34 amRNSMHP SE Notice of Annual General Meeting
5th May 20267:04 amRNSFinancial Results for the Q4 and 12M
17th Feb 20261:10 pmRNSMHP 2026 NOTES REDEMPTION PRICE ANNOUNCEMENT
13th Feb 20269:34 amRNSMHP LUX S.A. ANNOUNCES RESULTS OF TENDER OFFER
10th Feb 202610:32 amRNSMHP SE TAP OFFERING CLOSING ANNOUNCEMENT
4th Feb 20267:00 amRNSMHP Tap Pricing Announcement
3rd Feb 20269:11 amRNSMHP Tap Launch Announcement
28th Jan 202611:21 amRNSMHP NEW EUROBOND CLOSING ANNOUNCEMENT
22nd Jan 20267:00 amRNSMHP SE - Eurobond 2026 - Pricing Announcement
15th Jan 20261:28 pmRNSMHP 2026 NOTES CONDITIONAL REDEMPTION ANNOUNCEMENT
15th Jan 20261:12 pmRNSMHP SE NEW EUROBOND MANDATE AND TENDER OFFER
15th Jan 202612:57 pmRNSMHP LUX S.A. - INVITATION TO PURCHASE NOTES
15th Dec 20257:00 amRNSMHP SE Financial Results for the Q3 and 9 M 2025
9th Dec 20252:07 pmRNSMHP SE Results of EGM 09 December 2025
14th Nov 20252:14 pmRNSNotification about GDRs Purchase by PDMR of MHP
7th Nov 20258:25 amRNSConvening Notice of Extraordinary General Meeting
12th Sep 20257:00 amRNSFinancial Results for the Q2 and 6M 2025
4th Aug 20257:00 amRNSMHP Closes Acquisition of 92% Stake in Grupo UVESA
16th Jun 20251:39 pmRNSMHP SE Results of AGM 2025
21st May 20257:00 amRNSFinancial Results for the First Quarter 2025
14th May 20258:58 amRNSNotice of Annual General Meeting 2025
28th Apr 20257:09 amRNSFinancial Results Q4 and 12M 2024
28th Apr 20257:00 amRNSMHP acquires 91.77% of UVESA
21st Mar 20257:00 amRNSMHP signs Share Purchase Agreement with UVESA
11th Dec 20247:00 amRNSMHP offers to acquire UVESA Group
10th Dec 20241:08 pmRNSPress release on EGM result
22nd Nov 20247:10 amRNSFinancial Results for Q3 and 9M 2024
5th Nov 202411:33 amRNSNotice of Extraordinary General Meeting
17th Sep 202412:31 pmRNSDisclosure Notification
6th Sep 20249:29 amRNSFinancial Results for Q2 and 6M 2024 replace
19th Jun 202410:34 amRNSResults of AGM
4th Jun 20247:37 amRNSFinancial Results for the First Quarter 2024
17th May 20248:47 amRNSConvening Notice - AGM 2024
17th May 20247:22 amRNSBoard Changes
10th May 20247:58 amRNS2024 Eurobond Repayment
2nd May 20247:30 amRNS2023 Integrated Annual Report and Press Statement
11th Mar 20241:02 pmRNSEGM Results
7th Feb 202412:41 pmRNSEGM- Convening Notice
23rd Jan 20249:54 amRNSAppointment of a new ARC Chair
16th Nov 20237:13 amRNSQ3 and 9M 2023 Financial Results
25th Sep 20239:02 amRNSFinancial Statement Q2 2023
21st Sep 20237:06 amRNSDate Notification Q2 2023 Results
8th Sep 20237:00 amRNSMHP SE Invests in Saudi Arabia
19th Jun 20238:41 amRNSAGM results
18th May 20237:00 amRNSQ1 2023 Financial and Operational Results
17th May 202311:00 amRNSAGM Convening Notice
11th Apr 20239:42 amRNSMHP SE Standalone FS 2022
11th Apr 20239:27 amRNSMHP SE Standalone FS 2022
11th Apr 20238:54 amRNSMHP SE Standalone 2022

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.